In addition, it is possible that the hepatoprotective effect of QS-528 on this hepatotoxicity model is also associated with the ability of FFAR1 agonists to prevent the development of CCl4-induced fibrosis via the regulation of macrophages, fibroblasts/myofibroblasts and epithelial cells [11]. This evidence concerns the gene FFAR1 and fibrosis.